Suxamethonium
| Suxamethonium | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 290.40 g/mol [1] |
| Decomposition | When heated to decomposition it emits toxic fumes of nitroxides. [1] |
| Solubility | Very soluble [1] |
| Predicted LogP | 0.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C14H30N2O4+2 |
| IUPAC name | trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium |
| SMILES | C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C |
| InChI | InChI=1S/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2 |
| InChIKey | AXOIZCJOOAYSMI-UHFFFAOYSA-N |
| CAS number | 306-40-1 |
| UNII | J2R869A8YF |
| PubChem CID | 5314 |
| Pharmacokinetics[] | |
|---|---|
| Onset | 30–60 sec (IV), 2–3 min (IM) |
| Duration of action | < 10 min (IV), 10–30 min (IM) |
| Metabolism | By pseudocholinesterase, to succinylmonocholine and choline |
| Excretion | Kidney (10%) |
| Routes of administration | Intravenous, intramuscular |
| Toxicity [] | |
|---|---|
| LD50 | Mouse: - oral: 125 mg/kg - ip: 2140 μg/kg - sc: 7500 μg/kg - iv: 280 μg/kg Rabbit: - iv: 800 μg/kg [1] |
Suxamethonium (also known as Succinyldicholine, Succinocholine, Succinylbischoline, Succinoylcholine, Dicholine succinate, Diacetylcholine, Ditiline, Choline, succinyl-, Suxamethonium ion or Succinylcholine ion).
Chemistry
Stereochemistry []
Suxamethonium is achiral.
Druglikeness
Lipinski's rule of five
Suxamethonium matches Lipinski's rule of five.Pharmacology
ATC Classification
- musculo-skeletal system (M)
- muscle relaxants (M03)
- muscle relaxants, peripherally acting agents (M03A)
- choline derivatives (M03AB)
- (M03AB01)
- suxamethonium (M03AB01)
MeSH Classification
- neuromuscular depolarizing agents (M0014724)
Mechanism of action []
Succinylcholine is a depolarizing neuromuscular blocker, meaning it causes a prolonged period of membrane depolarization in order to exert its therapeutic effects. It binds to the post-synaptic cholinergic receptors found on motor endplates, thereby inducing first transient fasciculations followed by skeletal muscle paralysis. [1]
Medical side effects []
42 side effects listed on drug labels in SIDER 4.1 (succinylcholine).
- Anaphylactic shock
- Anaphylactoid reaction
- Apnoea
- Arrhythmia
- Bronchospasm
- Dermatitis
- Rash
- Muscle contractions involuntary
- Body temperature increased
- Flushing
- Cardiac arrest
- Hyperkalaemia
- Hypersensitivity
- Hypertension
- Hypotension
- Renal failure acute
- Hypertonia
- Muscle rigidity
- Myasthenia gravis
- Myoglobinuria
- Myoglobin urine present
- Porphyrin metabolism disorder
- Pulmonary oedema
- Renal failure
- Rhabdomyolysis
- Shock
- Salivary hypersecretion
- Tachycardia
- Tachyphylaxis
- Trismus
- Urticaria
- Ventricular fibrillation
- Myalgia
- Musculoskeletal discomfort
- Intraocular pressure increased
- Respiratory depression
- Pulmonary function test decreased
- Sputum increased
- Increased bronchial secretion
- Bradycardia
- Myoglobinaemia
- Respiratory failure
Indications
- Muscle relaxation
Legal status []
External links []
- Suxamethonium (Wikipedia)
- Suxamethonium (PubChem)
- Suxamethonium (Wikidata)
- Suxamethonium (DrugBank)
- Suxamethonium (ChEMBL)
- Suxamethonium (ChEBI)
- Suxamethonium (Common Chemistry)
- Suxamethonium (HMDB)
- Suxamethonium (KEGG)
- Suxamethonium (EPA DSSTox)
- Suxamethonium (Effect Index)
- Suxamethonium (UNII)
- Suxamethonium (SIDER)
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5314, Suxamethonium. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5314
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Suxamethonium. UNII: J2R869A8YF. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/J2R869A8YF
Product monograph brand safety updates. Health Canada. February 2024. https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/label-safety-assessment-update/product-monograph-brand-safety-updates.html
Anectine- succinylcholine chloride injection, solution. DailyMed. 17 September 2018. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a1e5d29f-111e-4a44-addf-beeb6ea81711
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 20:02:05 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 20:02:01 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 20:02:01 |
| gsrs | ok | 2026-11-20 20:02:01 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014347) | 2026-11-20 20:02:01 |
| kegg | ok | 2026-11-20 20:02:03 |
| pubchem | ok | 2026-11-20 20:02:00 |
| missing (no r/tripreports posts mention it) | 2026-11-20 20:02:01 | |
| sider | ok | 2026-11-20 20:02:01 |
| structure | ok | 2026-11-20 20:02:01 |
| wikipedia | ok | 2026-11-20 20:02:01 |